What type of study is this?

This is a Quantitative Study study.

October 3, 2025Clinical ChemistryOpen Access

B-338 Gestational Trophoblastic Disease (Hydatidiform Mole) with B-hCG Levels. Study of 2019 to 2024

View Full Paper

Ask AI

Bookmark

Authors

MFMárcia Cristina FeresAssociação Fundo de Incentivo à Pesquisa HCHugo CilottiAssociação Fundo de Incentivo à Pesquisa JDJose DichiricoAssociação Fundo de Incentivo à Pesquisa

Discussion

Member takes

Implication

This analysis examines hydatidiform mole types and beta-hCG levels in women with gestational trophoblastic disease, indicating diagnostic challenges ahead.

Key Points

The analysis revealed HUHM as the most frequent type of hydatidiform mole over the past six years.
Statistically significant differences were found between the types of moles (p=0.001), highlighting varied diagnoses.
Beta-hCG levels showed no significant differences both before and after the procedure among different mole types.
The findings underline the need for advanced molecular genetic testing to improve diagnoses of gestational trophoblastic diseases.

Cite This Study

Feres et al. (2025) studied this question.

synapsesocial.com/papers/68e040e5a99c246f578b2fd4 https://doi.org/10.1093/clinchem/hvaf086.725

View Full Paper

Ask AI

Bookmark

Implication

This analysis examines hydatidiform mole types and beta-hCG levels in women with gestational trophoblastic disease, indicating diagnostic challenges ahead.

B-338 Gestational Trophoblastic Disease (Hydatidiform Mole) with B-hCG Levels. Study of 2019 to 2024

Discussion

Member takes

Implication

Key Points

Cite This Study

B-338 Gestational Trophoblastic Disease (Hydatidiform Mole) with B-hCG Levels. Study of 2019 to 2024

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider